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in psoriasis. The past work on IL-l in CTCL was reviewed in our 
article, and its possible status in the pathogenesis oflesionallympho-
cyte infiltrates in MF discussed [2]. We were only able to conclude 
that the role ofIL-l in MF lesions is uncertain. If the lower levels of 
activity in lesional samples result from increased release of pre-
formed IL-l, then this cytokine may be pathogenically relevant. 
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REPLY 
We appreciate the comment of Lawlor et al on our results regarding 
IL-1a and IL-1P measurement in epidermal cell culture superna-
tants obtained from both normal and lesional CTCL skin [1]. Using 
enzyme-linked immunosorbent assay (ELISA) kits, we found a sig-
nificant but small increase of IL-1a protein release, but not IL-1P, 
from cultured lesional CTCL epidermal cells compared to cultured 
normal epidermal cells. In the t~ymo~yte-prol~feration assay, the 
IL-la protein was found to be bIOlogically actl~e. Because IL-la 
protein was increased and because the IL-1a protem was found to be 
active we concluded that IL-la activity was increased. Lawlor et al 
emphasize the importance of quantitative bioassays. However, such 
assays may not reveal the actual IL-l activity due to the presence of 
IL-l inhibitors that mask IL-l functional activity. 
LETTERS TO THE EDITOR 515 
It can be argued that measurements of IL-l in epidermal cell 
culture supernatants do not reflect the in vivo situation. We agree 
with this statement; however, we did stress both in the abstract as 
well as in the Materials and Methods and R esult section that our data 
reflect in vitro analysis. Furthermore, the lack of enhanced immuno-
reactivity in situ is not surprising because the ELISA technique is 
more sensitive when small changes have to be detected. 
The investigations performed by Lawlor et al used techniques by 
which an undefined part of the epidermis was removed by a scalpel 
[2] . The IL-l they assayed may in addition to the epidermal cells 
originate from fibroblasts , endothelial cells, and macrophages, as 
well as transudate from the vascular system. Therefore comparison 
of their results with ours is not possible. Neither do we think they 
can compare their result to Dr. Kevin Cooper's finding of decreased 
IL-la in psoriasis because homogenized keratome extracts and not 
skin chamber fluid was assayed in that study [3]. 
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Expression of Simple Epithelial Keratins in Epidermal Neoplasia Is Not 
Directly and Exclusively Related to Malignancy 
To the Editor: 
We read with great interest the paller by Markey et al in the N 0-
vember 1991 issue of the J oumal [1 J. Using a large panel of mono-
specific monoclonal antibodies against individual keratins, the au-
thors confirmed and extended previous reports on the expression of 
simple epithelial cytokeratin in pre-malignant (actinic keratosis), in 
situ malignant (Bowen's disease), and invasive malignant (squa-
mous cell carcinoma) skin lesions [2 - 5] . 
In their conclusion, Markey et al strongly favor a potential corre-
lation between de-differentiation of cytokeratin expression and the 
development of malignancy in keratinocytes. They furthermore 
suggest that "the aberrant expression of simple epithelial keratins 
may be an early marker for the genetic and epigenetic events that 
render keratinocytes capable of invasion." 
We would like to reconsider this conclusion in the presence of 
recent data on the cytokeratin expression in a benign epidermal 
tumor (seborrheic keratosis) [6], which are as follows. 1) A partial 
lack of cytokeratins K1 and K10, revealing a heterogeneous staining 
pattern of suprabasal keratinocytes (n = 10/10).2) K5-positive cells 
in suprabasal layers (n = 5/10). 3) A novel expression of simple 
epithelial cytokeratins (K8, K18, or K19, respectively, n = 8/10). 
4) The absence of ultrastructural characteristics of cells known to 
express simple epithelial keratins (such as sweat gland cells or Mer-
kel cells) in K-19 immunoreactive tumor cells. 
Based on these data we conclude that de-differentiation (or re-
differentiation towards embryonic keratinocytes?) of keratinocytes 
in terms of simple epithelial cytokeratin expression is not directly 
and exclusively related to malignant growth. But, in agreement 
with the authors' alternative hypothesis [1], it may suggest the im-
portance of mesenchymal factors in the regulation of cytokeratin-
